Vancomycin-intermediate Staphylococcus aureus (VISA) strains present an increasingly difficult problem in terms of public health. However, the molecular mechanism for this resistance is not yet understood. In this study, we define the role of the msaABCR operon in vancomycin resistance in three clinical VISA strains, i.e., Mu50, HIP6297, and LIM2. Deletion of the msaABCR operon resulted in significant decreases in the vancomycin MIC (from 6.25 to 1.56 g/ml) and significant reductions of cell wall thickness in strains Mu50 and HIP6297. Growth of the mutants in medium containing vancomycin at concentrations greater than 2 g/ml resulted in decreases in the growth rate, compared with the wild-type strains. Mutation of the msaABCR operon also reduced the binding capacity for vancomycin. We conclude that the msaABCR operon contributes to resistance to vancomycin and cell wall synthesis in S. aureus.
S
taphylococcus aureus is an important public health pathogen in both community and health care settings. Staphylococcal infections can be superficial (e.g., skin and soft tissue infections) or life-threatening (e.g., toxic shock, endocarditis, and septicemia) (1) . One of the key attributes of S. aureus as a pathogen is the acquisition of antibiotic resistance, as evidenced by the rise and widespread prevalence of methicillin-resistant S. aureus (MRSA) strains. The recent emergence of community-acquired MRSA strains that are hypervirulent has worsened the crisis (2, 3) . Indeed, since the 1990s, MRSA strains have been responsible for one-third of all S. aureus infections worldwide (4) . The glycopeptide antibiotic vancomycin has been used successfully to treat MRSA infections (1) . However, vancomycin resistance in S. aureus is becoming increasingly prevalent.
Vancomycin-nonsusceptible S. aureus (VRSA) strains have been classified into two major groups, based on their levels of resistance. According to the Clinical and Laboratory Standards Institute (CLSI), S. aureus strains are considered vancomycin-sensitive S. aureus (VSSA) strains if their MICs for vancomycin are Յ2 g/ml. Strains with MICs of 4 to 8 g/ml are considered vancomycin-intermediate S. aureus (VISA) strains, while strains that show vancomycin MICs of Ͼ16 g/ml are classified as vancomycin-resistant S. aureus (VRSA) strains. The prevalence of VRSA strains is very low, compared with that of VISA strains, which are more commonly encountered (5) .
VISA strains were first reported in 1997 and have emerged as a serious health care problem because of the extensive use of vancomycin in health care settings (6) . Since then, MRSA strains with intermediate-level resistance to vancomycin have been isolated from all over the world (7) (8) (9) (10) (11) (12) (13) (14) (15) . In clinical settings, patients with VISA infections tend to have comorbidities such as end-stage renal disease, diabetes mellitus, or cancer and usually have received a prolonged course of vancomycin prior to the isolation and detection of VISA. Infections often occur in biomedical devices such as catheters and do not respond well to vancomycin (16) .
The mechanism of resistance in VISA strains is still not completely understood, despite extensive studies. Vancomycin targets the cell wall and inhibits its synthesis by attaching to the D-Ala-DAla terminus of the pentapeptide side chain of undecaprenyl phosphate-N-acetylmuramic acid (MurNAc)-pentapeptide. Reduced susceptibility to vancomycin in VISA strains has been attributed to multiple cellular and genetic mechanisms, including a thickened cell wall (17) , reduced autolytic activity (18) , increased proportions of nonamidated muropeptides (19) , and reduced cross-linking between murein monomers caused by downregulation of penicillin-binding protein 4 (PBP4) (20, 21) , which ultimately leads to accumulation of D-Ala-D-Ala pseudotargets in the cell wall (22) . In addition, VISA strains display altered expression of several genes. These genes include atl (major autolysin), lytM (peptidoglycan hydrolase) (18) , sceD (transglycosylase) (23) , mprF (lysyl-phosphatidyl glycerol) (24) , dltA (teichoic acid biosynthesis regulator), sigB (25) (26) (27) (28) , ddh (29, 30) , tcaA (31) , and the two-component systems graSR, vraSR, and walKR (32) . However, we do not have a good understanding of how VISA strains avoid the bactericidal effects of vancomycin. It is clear that resistance to vancomycin is complex and involves more genes than have been identified to date.
Previously, we identified and characterized the msaABCR operon and showed that it positively regulates expression of sarA, biofilm development, and virulence (33) (34) (35) . Specifically, the msaABCR operon is a four-gene operon composed of msaA (SA1235), msaB (SA1234), msaC (SA1233), and newly discovered msaR antisense RNA (35) . Another phenotype observed in the msaABCR operon mutant was increased autolysis after induction with Triton X-100 (Fig. 1) . Reduced rates of autolysis have been correlated with vancomycin-intermediate resistance in several VISA strains (18, 36) . Although the mechanism is not yet clear, there is evidence that suppressed autolysis leads to resistance against multiple cell wall-active antibiotics (37) . Additionally, in-activation of the sarA gene has been shown to lead to decreases in the vancomycin MICs of laboratory-derived VISA strains (38) . These findings led us to investigate the role of the msaABCR operon in the mechanism of resistance of S. aureus strains to cell wall-active antibiotics. In this study, we show that the msaABCR operon contributes to resistance to vancomycin in three clinical VISA strains, i.e., Mu50, HIP6297, and LIM2.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Wild-type and mutant strains of S. aureus are listed in Table 1 . Escherichia coli strain TOP10 (Life Technologies, Grand Island, NY) was used for molecular cloning experiments. Luria-Bertani medium was used for E. coli culture. Brain heart infusion (BHI) broth and agar were routinely used for culturing of all VISA strains, unless otherwise mentioned. Tryptic soy broth and agar were used for culturing of S. aureus strain RN4220. To maintain plasmids, appropriate antibiotics were added to the media at concentrations of 100 g/ml ampicillin for E. coli and 10 g/ml chloramphenicol for S. aureus.
Generation of deletion mutants and complementation. All plasmids and primers used in this study are listed in Tables 1 and 2 , respectively. Isogenic deletion mutants of the msaABCR operon were generated in the VISA strains Mu50, HIP6297, and LIM2 using the plasmid pKOR1, as described previously (39) . Briefly, approximately 1 kb of sequence upstream and downstream of the operon region was PCR amplified with operon deletion primers (Operon del 1 through 4). The PCR products were digested with the restriction enzyme BamHI and ligated. The ligation product was amplified again with the terminal AttB-containing operon deletion primers (Operon del 1 and 4) and recombined into pKOR1 using the BP Clonase kit (Life Technologies), resulting in pKOR1⌬msaABCR. This plasmid was introduced into S. aureus RN4220 by electroporation. The constructs were subsequently transduced into strains Mu50, HIP6297, and LIM2 using bacteriophage . Mutagenesis was performed using the method described by Bae and Schneewind (39) . The mutation was confirmed by PCR using terminal primers.
For trans-complementation, the low-copy-number plasmid pCN34 was used (40) . To replace the kanamycin (aphA-3) selection marker of pCN34 with a chloramphenicol marker, the cat gene was PCR amplified from pHV1249 (41) using the primers Cm-F and Cm-R to generate an ApaI-XhoI fragment, which was then cloned into pCN34, resulting in plasmid pCN34(Cm r ). A 1.7-kb BamHI-EcoRI fragment was then PCR amplified from the genomic DNA of S. aureus strain Mu50/HIP6297/ LIM2 using the primers Comp-F1 and Comp-R1 and was cloned into This study pCN34(Cm r ), generating the pCN34(Cm r )-msaABCR operon. This plasmid was introduced into S. aureus strain RN4220 by electroporation and subsequently was transduced into the deletion mutant strains. Complemented strains were always maintained in medium containing 10 g/ml chloramphenicol.
Triton X-100-induced autolysis. The autolysis assay was performed as described by Mani et al. (42) . Briefly, overnight cultures were normalized to an optical density at 600 nm (OD 600 ) of 0.05 in BHI broth containing 1 M NaCl. Cells were harvested at an OD 600 of 0.7, resuspended in autolysis buffer (0.05 M Tris-HCl [pH 7.5], 0.05% Triton X-100), and incubated at 37°C. OD 600 values were recorded each hour.
Vancomycin susceptibility assay. The antimicrobial susceptibility of all strains was measured in triplicate by the broth microdilution method, according to CLSI guidelines (43) . Mueller-Hinton broth supplemented with 2% NaCl (CSMHB) was used for all broth microdilution experiments. Antimicrobial-containing wells were inoculated with 5 ϫ 10 5 CFU/ml (44) . After overnight incubation at 35°C, wells were analyzed for visible bacterial growth, as indicated by turbidity. The lowest concentration of vancomycin that prevented bacterial growth was considered to be the MIC.
Growth curves. An aliquot of fresh bacterial culture was diluted to about 1 ϫ 10 5 CFU/ml in 25 ml of fresh BHI broth and grown at 37°C with shaking. The optical density was measured at 600 nm at various time points. To analyze the growth defect of the msaABCR operon mutants in vancomycin-containing medium, BHI broth supplemented with vancomycin at concentrations of 1, 2, and 3 g/ml was used. For replenishment of the medium in experiments determining prolonged growth curves, vancomycin at a concentration of 4 g/ml was added every 6 h.
Population analysis profiles. Population analysis helps to determine how many cells within a given number of cells are resistant to a range of concentrations of a particular antibiotic (17) . Overnight cultures of S. aureus strains Mu50 and HIP6297 and their respective mutant strains were diluted to 10 -4 and 10 -6 , and 100 l of each dilution was plated onto BHI agar plates containing various concentrations of vancomycin. Plates were incubated for 48 h at 37°C, and CFU were plotted on a logarithmic scale against the vancomycin concentration.
Transmission electron microscopy. Preparation and examination of S. aureus cells by transmission electron microscopy were performed as described previously (45) . Briefly, exponentially growing cells were fixed in 2% glutaraldehyde in 0.1 M sodium phosphate buffer and treated with 1% osmium tetroxide for 2 h at 4°C. Cells were dehydrated and embedded in low-viscosity embedding medium (Electron Microscopy Sciences). Ultrathin sections were stained with uranyl acetate and lead acetate. Cell wall thicknesses were measured using photographic images, at a final magnification of ϫ30,000. Fifteen cells of each strain, with approximately medial cuts, were measured, and results were expressed as the mean Ϯ standard deviation (SD). Statistical analysis was performed using MedCalc software (version 13). P values of Ͻ0.05 were considered significant.
Vancomycin binding assay. The degree of binding of vancomycin molecules to the cell walls of wild-type strains and their respective msaABCR operon deletion mutants was determined using a dot blotting technique. Specifically, overnight cultures were diluted to an OD 600 of 0.05 in BHI broth containing no antibiotics. When the cells reached the mid-log phase, vancomycin was added to the culture at a concentration of 4 g/ml. After 1 h, 500 l of culture was collected and centrifuged to pellet the cells. Then, 10 l of the supernatant was loaded onto a nitrocellulose membrane and air dried. The membrane was then blocked with nonfat skim milk, incubated with an anti-vancomycin primary antibody and horseradish peroxidase (HRP)-conjugated secondary antibody, and treated with SuperSignal West Pico chemiluminescent substrate (Thermo 
Scientific, Rockford, IL). The intensity of the signal was measured using ImageJ software (46) . RNA extraction, reverse transcription, and quantitative reverse transcription-PCR. An aliquot of an overnight culture was normalized to an OD 600 of 0.05 and grown to exponential phase. At that time, a dose of 4 g/ml vancomycin was added to the culture. A control culture in which no vancomycin was added was maintained ("none" condition). Cells were grown for 1 h and harvested by centrifugation. The bacterial pellet was treated with RNAprotect Bacteria reagent (Qiagen, Valencia, CA) and stored at Ϫ80°C. RNA from the pellet was isolated using the RNeasy minikit (Qiagen) and dissolved in diethyl pyrocarbonate (DEPC)-treated water. RNA quality was analyzed by determining the 260-nm/280-nm absorbance ratio using a Nanodrop spectrophotometer (Thermo Scientific). Reverse transcription was carried out with 1 g of RNA using the iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA), according to the manufacturer's instructions. All real-time PCRs were performed in triplicate. The primers used for real-time PCR are listed in Table 2 . The fold change in gene expression was calculated using the 2 Ϫ⌬⌬Ct formula (47), using the gyrA gene as an internal control. Fold change values were statistically analyzed with the independent-sample t test, using MedCalc software.
Absolute quantification of the sigB transcript. Absolute quantification of the sigB transcript was performed by the method previously described by Chini et al. (48) . Briefly, the sigB and gyrA genes were amplified from chromosomal DNA using primers external to the primers used for quantitative reverse transcription (qRT)-PCR. These amplicons were purified, and their concentrations were measured using a Nanodrop spectrophotometer. The corresponding concentrations were converted to copies per microliter by a previously described method (49) . Tenfold serial dilutions (range, 10 2 to 10 6 ) of these amplicons were used as templates for qRT-PCR. Standard curves were generated by plotting threshold cycle (C T ) values against the log of the copy numbers (log starting quantity [SQ]). Starting quantities of "unknown" samples (wild-type and mutant cDNA) were calculated by plotting the respective C T values on the standard curve. Copy numbers were measured by raising 10 to the power of the SQ (10 SQ ). Copy numbers of sigB were normalized to those of gyrA and plotted. The process was repeated in triplicate independently.
Membrane purification and PBP detection. For detection of PBPs, membranes were prepared from wild-type and msaABCR mutant strains following the method described by Sieradzki et al. (13) , with some modifications. Briefly, cells were grown to the late exponential phase, harvested, washed once with wash buffer (50 mM Tris, 150 mM NaCl, 5 mM MgCl 2 [pH 7.5]), and resuspended in the same buffer with 0.5 mM phenylmethylsulfonyl fluoride and 10 mM ␤-mercaptoethanol. Cells were then treated with lysostaphin (100 g/ml), DNase (20 g/ml), and RNase (10 g/ml) for 30 min on ice, followed by sonication. Broken cells and membranes were harvested by centrifugation at 110,000 ϫ g for 40 min at 4°C and washed with 50 mM phosphate buffer (pH 7). Membranes were solubilized with 2% Triton X-100. Protein concentrations were measured using the bicinchoninic acid (BCA) protein assay kit (Pierce) and a standard curve prepared with serial dilutions of bovine serum albumin.
PBPs were detected using a method described by Atilano et al. (50), with some modifications. Briefly, 10 g of membrane proteins were mixed with 100 M Bocillin-FL (Life Technologies) and incubated for 10 min at 30°C. The reaction was stopped by the addition of 5ϫ SDS-PAGE sample buffer. Samples were separated on a 4 to 20% gradient gel, and labeled proteins were detected with Alexa Fluor 488 using a Bio-Rad VersaDoc system. The gel images were analyzed and quantified using ImageJ software.
RESULTS AND DISCUSSION
Deletion of the msaABCR operon increased susceptibility to vancomycin in three VISA strains. Several studies have demonstrated that global regulators such as sarA and sigB are involved in vancomycin resistance (38, 51) ; however, the mechanism of regulation is not yet understood (26, 52) . Because msaABCR is a positive regulator of sarA and a negative regulator of autolysis and, as mentioned earlier, both the expression of sarA and a decreased rate of autolysis have been shown to be important for the VISA phenotype, we attempted to understand the effect of the msaABCR operon on vancomycin resistance in VISA strains.
We deleted the msaABCR operon in three different clinical VISA strains, i.e., Mu50 (SCCmec type II, sequence type 5 [ST5]), HIP6297 (SCCmec type II, ST5), and LIM2 (SCCmec type I, ST247). Mu50 is a hospital-associated VISA strain that was isolated in 1997 from pus from a Japanese boy with a postsurgical infection that was not responsive to vancomycin treatment (6) . This isolate has a vancomycin MIC of 8 g/ml (6), a thick cell wall, relative to its susceptible isogenic strain (19) , reduced autolytic rates (18) , reduced cell wall cross-linking (53) , and an increased number of pentapeptide side chains (19) . HIP6297 is a hospitalassociated strain that was recovered from the bloodstream of a 79-year-old man with renal disease, an internal jugular catheter infection, and bacteremia, at a hospital in New York, New York (13) . HIP6297 has a vancomycin MIC of 8 g/ml and a thick cell wall (13) . LIM2, another hospital-associated VISA strain, was isolated from a 2-year-old girl with an MRSA infection that was not responsive to vancomycin treatment, in a French hospital (54) . Deletion of the msaABCR operon caused significant decreases in vancomycin MICs in all three VISA strains. Specifically, the MICs of all three strains decreased from an intermediate resistance level of 6.25 g/ml to a susceptible level of 1.56 g/ml (Table 3) . Reintroduction of the msaABCR operon, cloned in the low-copy-number plasmid pCN34, into the deletion mutants led to increases in the MICs to 3.125 g/ml, confirming that the MIC decreases were due to deletion of the msaABCR operon (Table 3) . Although the MICs of the complemented mutants were not in the VISA range of 4 to 8 g/ml vancomycin, they were higher than the vancomycinsensitive S. aureus (VSSA) range of 2 to 4 g/ml. We used the VSSA strain N315 as a control in this study. N315 is genetically related to strain Mu50 (55) . As expected, deletion of the msaABCR operon in N315 did not change the vancomycin MIC. These findings indicate that the msaABCR operon is essential for vancomycin resistance in VISA strains.
One of the hallmarks of VISA strains is the significant change in their growth rates relative to their sensitive counterparts (19) . We measured the growth rates of the deletion mutants at different vancomycin concentrations (1, 2, and 3 g/ml). We found that wild-type strains displayed steady growth rates and reached a stationary phase after 6 h at all three concentrations of vancomycin, whereas the three mutant strains did not show any growth after 6 h at a vancomycin concentration of 2 g/ml or higher (Fig. 2) . Interestingly, all of the mutants showed growth after a 20-h lag period unless the medium was replenished with vancomycin ( Fig. 3) . This observation supports previous findings by Cui et al. (19) and confirms the increased susceptibility of the msaABCR operon mutant to vancomycin. To further characterize the population of the deletion mutants with regard to vancomycin resistance, we evaluated the homogeneity of the cells using a population analysis profile (17) (Fig. 4) . With wild-type strain Mu50, 10 10 cells/ml were resistant to vancomycin at concentrations up to 3 g/ml and 10 7 cells/ml were resistant to a vancomycin concentration of 4 g/ml. This indicated a small degree of heterogeneity in resistance. With the Mu50 msaABCR operon mutant, however, 10 9 cells/ml were resistant to a vancomycin concentration of 1 g/ml but no cells were resistant to a vancomycin concentration higher than 1 g/ml. This indicated that the msaABCR operon mutant had a homogeneously sensitive population structure with regard to vancomycin. Similarly, in the case of HIP6297, 10 10 cells/ml were resistant to 4 g/ml vancomycin and 10 9 cells/ml were resistant to 5 g/ml vancomycin. The msaABCR operon mutant, however, possessed 10 9 resistant cells per ml in the presence of 3 g/ml vancomycin and no resistant cells at higher concentrations. Wild-type LIM2 maintained 10 10 cells/ml up to 5 g/ml vancomycin, whereas its msaABCR operon mutant maintained 10 8 cells/ml only up to 2 g/ml vancomycin. These results indicated that mutation of the msaABCR operon led to a population of cells that were homogeneously sensitive to vancomycin. These results also suggested that the msaABCR operon is a regulator of resistance to vancomycin. Population analysis revealed that all three mutants were homogeneously sensitive to vancomycin. Indeed the msaABCR deletion mutants did not show any resistant subpopulations in the presence of vancomycin at concentrations greater than 3 g/ml.
This phenotype is of significance for the clinical treatment of VISA infections because some VISA strains, such as Mu50, have been shown to maintain a subpopulation resistant to vancomycin. Indeed, Cui et al. (17) demonstrated that passage of strain Mu50 through a drug-free medium (35 days) led to a drop in the vancomycin MIC from 8 g/ml to 2 g/ml. However, population analysis of the passage-derived strain revealed a resistant subpopulation that was able to grow in the presence of up to 8 g/ml vancomycin (17) . Such VISA strains have been defined as hetero-VISA (h-VISA) strains and present a treatment challenge. They are difficult to treat because of the rise of resistant subpopulations during treatment with vancomycin. For instance, the hetero-VISA strain Mu3, which is isogenic with respect to Mu50, was isolated from a Japanese male patient who was unresponsive to vancomycin treatment. While Mu3 was initially characterized as susceptible to vancomycin (MIC ϭ 2 g/ml) according to CLSI criteria (56) , when it was grown in the presence of a high concentration of vancomycin (2 to 9 g/ml) it produced resistant subclones with MICs of 6 to 8 g/ml (comparable to that of Mu50) at a frequency of 1 per 10 6 . This is relevant to patients infected with h-VISA strains, for whom peak tissue concentrations of vancomycin can range from 2 to 5 g/ml, depending on the dosage and frequency of treatment (57) . These studies show that the rise of a resistant subpopulation is likely; however, the mechanism that leads to this is not yet understood. The absence of resistant subpopulations in the msaABCR operon deletion mutants is therefore very interesting and suggests a role of the operon in this process. Targeting regulators such as the msaABCR operon, which eliminates h-VISA strains, could be potentially beneficial in developing new treatments for VISA infections.
Previously, sarA and sigB inactivation in laboratory-derived vancomycin-resistant/intermediate strains also resulted in decreases in vancomycin MICs. Singh et al. (51) demonstrated that a sigB deletion mutant of the laboratory-derived strain 13136p Ϫ m ϩ V 20 had a vancomycin MIC of 4 to 6 g/ml after population analysis, in comparison with the wild-type strain, which had a vancomycin MIC of 12 to 14 g/ml. The population analysis profile of the mutant strain displayed a homogeneously sensitive population structure. Similarly, in a study by LamichaneKhadka et al. (38) , the sarA insertion mutant of BB270V 15 showed a MIC of 3 g/ml in agar dilution analysis, while the wild-type strain showed a vancomycin MIC of 8 g/ml. In the population analysis profile, the mutant displayed a homogeneously sensitive population structure. These findings support our hypothesis that mutation of major global regulators could have a profound effect on the vancomycin resistance of VISA strains and may render the strains homogeneously sensitive to vancomycin, which could be clinically beneficial.
The msaABCR operon regulates cell wall morphology. Vancomycin is an inhibitor of cell wall synthesis in S. aureus and other Gram-positive bacteria. It binds to the D-Ala-D-Ala residues of the pentapeptide side chain of undecaprenyl phosphate-MurNAcpentapeptide, a cell wall precursor, and forms a stable noncovalent complex. As a result, this complex cannot be used in the biosynthesis of the cell wall (58) . VISA strains, including Mu50 and HIP6297, have thick cell walls, relative to their sensitive counterparts (13, 17, 19, 45, 59, 60) . Cui et al. (17) showed that cell wall thickening is the most consistent feature of vancomycin-intermediate and -resistant strains. They also showed a positive correlation between the thickness of the cell wall and vancomycin MICs Samanta and Elasri in a study of 48 S. aureus strains, including VISA and VRSA strains.
We examined the cell wall thickness of the msaABCR operon mutants using transmission electron microscopy. Mutants of Mu50 and HIP6297 showed significant decreases (50%) in cell wall thickness and a smoother texture, relative to their wild-type strains (Table 4 and Fig. 5A and B) . These results suggest that the msaABCR operon plays a role in cell wall synthesis and contributes to cell wall thickness in VISA strains.
The main location of cell wall synthesis in S. aureus has been shown to be the tip of the division septum of a bacterium and not the entire plasma membrane surface (61) . Therefore, for vancomycin to prevent cell wall synthesis, it would have to diffuse through the cell wall to the tip of the division septum, which is approximately a 25-nm path (62) . Pfeltz et al. proposed that a thickened cell wall increases the path that vancomycin has to travel, preventing the diffusion of vancomycin molecules from the environment to the cell's active site, which is the tip of the division septum in the cytoplasmic membrane (22, 63) . This enables VISA and VRSA strains to continue synthesizing peptidoglycan and to survive in a vancomycin-containing environment. Our results suggest that the observed sensitivity of msaABCR operon mutants to vancomycin may be due to the decrease in cell wall thickness.
As stated earlier, one of the key phenotypes of the msaABCR operon mutants involves the prolonged lag phase in vancomycincontaining medium, which may be due to thinning of the cell wall. A study comparing VSSA and VISA strains found that the length of the lag phase was negatively correlated with cell wall thickness (17, 19) . It was proposed that a thin cell wall binds vancomycin molecules at a significantly lower rate than in the wild-type strains and therefore removes drug molecules from the medium at a lower rate, which results in a prolonged lag phase. Indeed, we observed a 3-fold decrease in the binding of vancomycin molecules to the cell wall of the msaABCR mutants, compared with the respective wild-type cells (Fig. 6 ). To date, however, the mechanistic link between the length of the lag phase and the thickness of the cell wall has not been defined.
The msaABCR operon regulates the expression of pbp4, sigB, and mprF in a strain-dependent manner. Studies with VISA strains have yielded descriptive assessments that correlate various phenotypes with intermediate vancomycin resistance. Collectively, these studies have resulted in a set of phenotypes that are commonly observed in VISA strains. Several studies have also used a variety of approaches to identify specific genes that are associated with vancomycin resistance; these include expression studies (e.g., microarray analysis) (26, 27, 52) and comparisons of isogenic resistant and sensitive strains in targeted mutagenesis experiments (1, 24, 32, 38, 51, 64, 65) . Collectively, these studies have identified the following regulator genes as critical to intermediate vancomycin resistance in S. aureus: pbp4, sigB, walKR, graS, graR, mprF, dltA, vraS, vraR, and sarA.
We examined the expression of these genes in the msaABCR operon mutants using qRT-PCR, in the absence and presence of vancomycin. No significant changes in gene expression were observed for graR, graS, dltA, vraSR, and walKR in either of the strains. However, we found that expression of pbp4 was increased and that of sigB was decreased in the Mu50 msaABCR mutant and expression of mprF was decreased in the HIP6297 msaABCR mutant (see Fig. S1 and S2 in the supplemental material).
The msaABCR mutant of Mu50, but not HIP6297, showed a 3-fold increase in pbp4 expression both in the presence and in the absence of vancomycin (see Fig. S1 in the supplemental material). We confirmed the increase in the expression of PBP4 in the Mu50 msaABCR operon mutant by performing a fluorescent penicillinbinding assay with Bocillin-FL, to measure the levels of PBP4 protein. We found that the Mu50 msaABCR operon mutant produced 6.003-fold higher levels of PBP4 than did the wild-type strain (Fig. 7) . PBP4 is involved in cell wall biosynthesis as a DD-carboxypeptidase enzyme (66) . PBP4 is required for cleavage of the peptide bond of the D-Ala-D-Ala residues of the pentapeptide side chain of undecaprenyl phosphate-MurNAc-pentapeptide prior to cross-linking between the penultimate alanine and the third lysine of another MurNAc group. Because vancomycin binds to D-Ala-D-Ala residues, any vancomycin-bound residue becomes unavailable for PBP4 and therefore cannot be used for cross-linking. VISA strains produce significantly less PBP4 than do VSSA strains (20, 67) . Deletion of pbp4 in the VSSA strain N315 caused an increase in the vancomycin MIC, which was restored by complementation of pbp4, suggesting that the function of pbp4 is directly related to the vancomycin MIC (20) . Although the genetic regulation of pbp4 in VISA strains is not yet understood, it has been proposed that reduced expression of PBP4 in VISA strains results in an increase of intact D-Ala-D-Ala and consequently a buildup of non-cross-linked muropeptide monomers in the cell wall. These monomers hinder the diffusion of vancomycin molecules by attaching the drug molecules to the intact D-Ala-D-Ala termini. The attached vancomycin molecules are thought to become part of the resistance mechanism by sterically hindering additional vancomycin molecules during the diffusion process (68) . These findings indicate that there is a negative correlation between the pbp4 expression level and resistance to vancomycin. Hence, our results suggest that the msaABCR operon negatively controls the expression of pbp4 in Mu50 and the increased sensitivity of the Mu50 msaABCR mutant to vancomycin may be attributed to the increased PBP4 activity. Further studies are needed to define the relationship between the msaABCR operon, PBP4 activity, and the amounts of cross-linking in the cell wall.
Gram-positive bacteria respond to stress by expressing alternative sigma factors such as sigma B (encoded by sigB). The presence of antibiotics, such as methicillin or vancomycin, has been shown to activate the expression of sigma B in S. aureus, implicating this factor in antibiotic resistance (51, 69, 70) . Expression of sigB was significantly reduced in the msaABCR mutant of the Mu50 strain, compared with the wild-type strain, in both the absence (4.91-fold) and the presence (7.15-fold) of vancomycin. Expression of asp23, which is directly under the regulation of sigB, was also downregulated in Mu50. Interestingly, this change in expression was not observed in strain HIP6297, indicating that this regulatory effect is strain dependent. Mutation of sigB has been shown to reduce vancomycin resistance in a passagederived resistant strain of S. aureus (51) . Conversely, activation or overexpression of sigB led to thickening of the cell wall and increased vancomycin resistance in VSSA strain N315 (25, 28) . Cell wall inhibitor antibiotics induce a stress response in S. aureus cells (63). Resistant cells may have the capacity to respond to and counteract the stress more efficiently than their sensitive counterparts. We propose that the msaABCR operon mutant of Mu50, with decreased sigB expression, becomes more susceptible to stress conditions, including the presence of vancomycin in the medium. However, the mechanism by which the msaABCR operon regulates sigB and the reasons why this regulation occurs in strain Mu50 but not in strain HIP6297 are currently unclear.
Another regulator that is directly under the control of the stress response system, mprF, was found to be significantly downregulated in the msaABCR operon deletion mutant of HIP6297 but not that of Mu50. MprF is a putative transmembrane protein that mediates the biosynthesis of lysylphosphatidylglycerol (24) . It is a positively charged phospholipid that contributes to a net positive charge on the cell surface. mprF-deficient mutants have been shown to be sensitized to cationic antimicrobial peptides of the immune system (71, 72) and vancomycin (24) . This phenotype was attributed to the fact that, because MprF mediates the synthesis of a positively charged lipid, its absence leads to the accumulation of a net negative charge on the cell surface, which attracts cationic or positively charged molecules, including vancomycin. Ruzin et al. (24) showed that an mprF mutant indeed bound more vancomycin to the membrane than the corresponding wild-type strain. This may contribute to the increased susceptibility of the HIP6297 msaABCR operon deletion mutant to vancomycin.
The strain-dependent variations among VISA isolates, in terms of both phenotype and genetic mutations, are not uncommon. Reduced vancomycin sensitivity has been reported to be unstable for some isolates such as HIP5836 and Mu50 (73) but not for laboratory-derived passage-selected VISA strains such as BB270V 15 , COLV 10 , and 13136p Ϫ m ϩ V 20 (63). Cell wall thickening has been shown in most VISA isolates but to different degrees. For instance, the thickness of the cell wall in strains JH9 and JH14 (22) appears to be many fold higher than that observed in strain Mu50. Reduced cross-linking of the muropeptides appears to be correlated with the vancomycin MIC in many VISA strains but not all (7). Boyle-Vavra et al. (7) demonstrated that a vancomycin-trapping hypothesis and a uniform cascade of genetic events might not explain the resistance phenotype in every VISA strain isolated. In this study, however, reorganization of the cell wall was found to be common among all VISA isolates. Nonamidated glutamic acid residues have been shown to play a role in the resistance mechanism of some but not all VISA strains (53) . Similarly, many genes have been correlated with vancomycin resistance, in terms of either altered expression or point mutations, but none has been found to be present without exception. In analyses of the results of multiple studies (1, 20, 26, 68) , it appears that, although theoretically decreased expression of PBP4 could be correlated with higher vancomycin MICs, the laboratory-derived VISA mutants do not follow this pattern.
Strain-dependent variations are also found in terms of mutations in response regulator genes. Although mutations in genes such as vraSR, graSR, clpP, and walKR have been correlated with a VISA phenotype, sequence analysis of these genes in 39 VISA isolates revealed that none of these mutations is present among all VISA strains (1). While 27 VISA strains possessed mutations in walK, only a few of those mutations were at the same site in the gene. Similarly, three isolates harbored mutations in clpP, four isolates had mutations in graR, and eight isolates had vraS mutations, but all of those mutations were at different sites within the genes. Shoji et al. proposed that these differences indicate the existence of alternative pathways for the establishment of vancomycin resistance in different VISA isolates (1).
Strain-dependent variation has also been observed in the function of global regulators in S. aureus. Zielinska et al. studied the regulatory role of sarA in the alpha-toxin phenotype of laboratory and clinical strains of S. aureus, and they observed that sarA exerts strain-dependent effects on the transcription of RNAIII and hla (74) . Blevins et al. also demonstrated strain-dependent regulatory roles for sarA and agr (75) . In this context, variations between strains Mu50 and HIP6297 would be expected. For instance, Mu50 harbors one mutation in VraS (I5N) and one in GraR (N197S); HIP6297 possesses neither of these but possesses a mutation in WalK (A567D) (1) . Although Mu50 and HIP6297 strains have been described to have inactivated PBP4 (68), our results indicate that the msaABCR operon exerts a strain-dependent effect on pbp4 expression.
Strain variations in VISA isolates, such as the ones in this study, have made it difficult to define a common mechanism for establishment of the VISA phenotype. In conclusion, we have shown that the msaABCR operon plays a key role in intermediate vancomycin resistance and its inactivation leads to homogeneous vancomycin sensitivity despite strain differences.
